+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medications for Alcohol Use Disorder Market - Global Forecast 2026-2032- Product Image
Medications for Alcohol Use Disorder Market - Global Forecast 2026-2032- Product Image
Sale

Medications for Alcohol Use Disorder Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6128500
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medications for Alcohol Use Disorder Market is projected to reach USD 1.20 Billion in 2026. It is expected to continue growing at a CAGR of 10.11%, reaching USD 2.17 Billion by 2032.

Medications for Alcohol Use Disorder: Executive Summary

Medications for alcohol use disorder (AUD) support a broader treatment approach that combines pharmacotherapy with screening, counseling, peer support, and management of co-occurring conditions. Commonly used options include naltrexone, acamprosate, and disulfiram, while other medicines may be used selectively or off label according to clinical judgment and local guidance. Treatment decisions depend on drinking patterns, withdrawal risk, liver and kidney function, pregnancy status, medication interactions, patient preferences, and access to follow-up care.

Treatment Is Shifting Toward Integrated, Patient-Centered Care

AUD care is moving away from viewing medication as a stand-alone intervention. Clinical practice increasingly emphasizes screening in primary care and emergency settings, rapid linkage to treatment, shared decision-making, relapse-prevention planning, and coordination with mental-health and addiction services. Long-acting formulations, telehealth, pharmacy-based support, and digital adherence tools can help address continuity challenges, although their usefulness depends on clinical oversight, affordability, privacy protections, and reliable connectivity.

Artificial Intelligence Can Strengthen Identification and Continuity of Care

Artificial intelligence can support AUD services by helping identify risk in electronic health records, prioritizing patients for screening, assisting documentation, and detecting missed visits or medication gaps. Predictive tools should augment rather than replace clinician assessment because alcohol-use data can be incomplete, biased, or sensitive. Safe implementation requires transparent validation, human review, strong privacy safeguards, equitable performance across populations, and clear escalation pathways for withdrawal, overdose risk, suicidality, or other urgent needs.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America generally emphasizes primary-care integration, evidence-based pharmacotherapy, and telehealth, while affordability and uneven access remain important barriers. Latin America faces variation in specialist capacity, medicine availability, and continuity of care, increasing the value of decentralized screening and workforce training. Europe benefits from established public-health and addiction-care systems, but national formularies and referral pathways differ. In the Middle East and Africa, stigma, limited specialist infrastructure, and confidentiality concerns can constrain treatment engagement. Asia-Pacific combines advanced health systems with substantial rural and geographic diversity, making culturally appropriate outreach, primary-care capability, and digital access particularly relevant.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Require Coordinated but Tailored Approaches

ASEAN members may benefit from adaptable primary-care protocols and cross-border learning that reflect differing health-system capacity and cultural contexts. BRICS economies require approaches that address large internal disparities, workforce shortages, and medicine access across urban and rural settings. The European Union can build on clinical-guideline alignment while recognizing national reimbursement and service-delivery differences. G7 countries can prioritize quality measurement, integrated mental-health care, and responsible digital innovation. GCC systems may focus on confidential, accessible services and workforce specialization. NATO members, considered as a health-policy grouping rather than a treatment system, can share lessons on trauma-informed care, veteran health, and continuity across civilian and service settings.

Country Conditions Shape Medication Access and Clinical Delivery

Australia and Canada can continue strengthening primary-care and remote-care pathways. Brazil, Mexico, India, China, Russia, and South Africa require attention to regional disparities, specialist availability, and consistent medicine supply. France, Germany, Italy, Spain, and the United Kingdom can refine coordination between primary care, specialist addiction services, and mental-health care while accounting for national reimbursement structures. Japan and South Korea may benefit from approaches that reduce stigma and improve earlier engagement. Across the United States, expanding screening, treatment initiation, follow-up, and coverage navigation remains important, particularly for underserved communities. In every country, local regulatory requirements and clinical guidelines should govern medication selection and monitoring.

Industry Leaders Should Prioritize Access, Adherence, Evidence, and Trust

Organizations should develop integrated care pathways that allow prompt assessment, withdrawal-risk triage, medication initiation when appropriate, and scheduled follow-up. They should support prescriber education, pharmacist involvement, patient decision aids, adherence services, and referral networks for counseling and recovery support. Access strategies should address affordability, rural delivery, language, stigma, and continuity after acute care. Leaders should measure initiation, retention, safety monitoring, patient-reported outcomes, and equity across demographic and geographic groups. Any AI-enabled capability should undergo clinical validation, bias testing, cybersecurity review, and ongoing human oversight.

Methodology Combines Clinical Guidance, Public-Health Evidence, and Health-System Context

This executive summary synthesizes established clinical principles for AUD pharmacotherapy with public-health and health-system considerations across the specified regions, groups, and countries. The analysis compares treatment-enabling factors such as screening, referral capacity, medication access, monitoring, stigma reduction, digital support, and integration with behavioral care. It does not provide market estimates, market shares, forecasts, or company-specific analysis. Country and grouping observations are presented as contextual insights and should be interpreted alongside current national guidelines, regulatory information, and local epidemiological evidence.

Sustainable Progress Depends on Integrated, Equitable, and Clinically Governed Care

Medications for AUD are most effective within accessible, patient-centered systems that combine appropriate pharmacotherapy with behavioral support, monitoring, and long-term follow-up. Regional and country differences make flexible implementation essential, while shared priorities include earlier identification, reduced stigma, reliable medicine access, and stronger continuity between care settings. Industry and health-system leaders can create the greatest value by improving treatment pathways, measuring equitable outcomes, and deploying digital and AI tools cautiously under clear clinical and privacy governance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medications for Alcohol Use Disorder Market, by Route of Administration
7.1. Introduction
7.2. Injectables
7.2.1. Injectable Intramuscular
7.2.2. Injectable Subcutaneous
7.3. Oral Tablets
8. Medications for Alcohol Use Disorder Market, by Drug Class
8.1. Introduction
8.2. Acamprosate
8.3. Baclofen
8.4. Disulfiram
8.5. Naltrexone
8.6. Topiramate
9. Medications for Alcohol Use Disorder Market, by Distribution Channel
9.1. Introduction
9.2. Online
9.3. Offline
10. Medications for Alcohol Use Disorder Market, by End User
10.1. Introduction
10.2. Hospitals
10.3. Research Institutes
10.4. Addiction Clinics
11. Medications for Alcohol Use Disorder Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Medications for Alcohol Use Disorder Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Medications for Alcohol Use Disorder Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Alkermes
15.2. Ambica Pharma
15.3. Amigoz Lifesciences
15.4. Care Formulation Labs Private Limited
15.5. Consern Pharma Limited
15.6. Dhritee Impex
15.7. Eisai Pharmaceuticals India Pvt Ltd
15.8. Intas Pharmaceuticals Ltd.
15.9. Johnlee Pharmaceuticals Pvt. Ltd.
15.10. Lifegenix (Div. of Lifecare Neuro Products Ltd.)
15.11. Mallinckrodt Pharmaceuticals
15.12. Marshall Healthcare
15.13. Odyssey Pharmaceuticals
15.14. Rusan Pharma
15.15. Salvavidas Pharmaceutical Pvt. Ltd.
15.16. Sanofi S.A.
15.17. Schwitz Biotech
15.18. Sun Pharmaceutical Industries Ltd.
15.19. Taj Pharmaceuticals
15.20. Teva Pharmaceutical Industries Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medications for Alcohol Use Disorder Market, Years Considered for the Study
FIGURE 2. Global Medications for Alcohol Use Disorder Market, Research Design
FIGURE 3. Global Medications for Alcohol Use Disorder Market, Research Framework
FIGURE 4. Global Medications for Alcohol Use Disorder Market, Data Triangulation
FIGURE 5. Global Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2025 vs 2032 (%)
FIGURE 7. Global Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medications for Alcohol Use Disorder Market Size, by Drug Class, 2025 vs 2032 (%)
FIGURE 9. Global Medications for Alcohol Use Disorder Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medications for Alcohol Use Disorder Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Medications for Alcohol Use Disorder Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medications for Alcohol Use Disorder Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Medications for Alcohol Use Disorder Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medications for Alcohol Use Disorder Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Medications for Alcohol Use Disorder Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Medications for Alcohol Use Disorder Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medications for Alcohol Use Disorder Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medications for Alcohol Use Disorder Market Segmentation & Coverage
TABLE 2. Global Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 4. Global Injectables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Injectables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Injectables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Injectable Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Injectable Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Injectable Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Injectable Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Injectable Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Injectable Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Oral Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Oral Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Oral Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 17. Global Acamprosate Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Acamprosate Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Acamprosate Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Baclofen Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Baclofen Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Baclofen Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Disulfiram Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Disulfiram Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Disulfiram Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Naltrexone Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Naltrexone Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Naltrexone Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Topiramate Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Topiramate Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Topiramate Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 33. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 40. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Addiction Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Addiction Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Addiction Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Medications for Alcohol Use Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Medications for Alcohol Use Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 56. North America Medications for Alcohol Use Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. North America Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 58. North America Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 59. North America Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 60. North America Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 61. North America Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 62. Latin America Medications for Alcohol Use Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Latin America Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 64. Latin America Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 65. Latin America Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 66. Latin America Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 67. Latin America Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Europe Medications for Alcohol Use Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Europe Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 70. Europe Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 71. Europe Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 72. Europe Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 73. Europe Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Middle East Medications for Alcohol Use Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Middle East Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 76. Middle East Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 77. Middle East Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 78. Middle East Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 79. Middle East Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Africa Medications for Alcohol Use Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Africa Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 82. Africa Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 83. Africa Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 84. Africa Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. Africa Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Global Medications for Alcohol Use Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. ASEAN Medications for Alcohol Use Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. ASEAN Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 89. ASEAN Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 90. ASEAN Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 91. ASEAN Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. ASEAN Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. GCC Medications for Alcohol Use Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. GCC Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 95. GCC Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 96. GCC Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 97. GCC Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. GCC Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. European Union Medications for Alcohol Use Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. European Union Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 101. European Union Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 102. European Union Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 103. European Union Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. European Union Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. BRICS Medications for Alcohol Use Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. BRICS Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 107. BRICS Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 108. BRICS Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 109. BRICS Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. BRICS Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. G7 Medications for Alcohol Use Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. G7 Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 113. G7 Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 114. G7 Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 115. G7 Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. G7 Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. NATO Medications for Alcohol Use Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. NATO Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 119. NATO Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 120. NATO Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 121. NATO Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. NATO Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Global Medications for Alcohol Use Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. United States Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 125. United States Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 126. United States Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 127. United States Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 128. United States Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. United States Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Canada Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 131. Canada Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 132. Canada Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 133. Canada Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 134. Canada Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. Canada Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. Mexico Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 137. Mexico Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 138. Mexico Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 139. Mexico Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 140. Mexico Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. Mexico Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Brazil Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 143. Brazil Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 144. Brazil Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 145. Brazil Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 146. Brazil Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Brazil Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. United Kingdom Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 149. United Kingdom Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 150. United Kingdom Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 151. United Kingdom Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 152. United Kingdom Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. United Kingdom Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Germany Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 155. Germany Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 156. Germany Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 157. Germany Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 158. Germany Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. Germany Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. France Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 161. France Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 162. France Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 163. France Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 164. France Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. France Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Russia Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 167. Russia Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 168. Russia Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 169. Russia Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 170. Russia Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. Russia Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Italy Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 173. Italy Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 174. Italy Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 175. Italy Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 176. Italy Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. Italy Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Spain Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 179. Spain Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 180. Spain Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 181. Spain Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 182. Spain Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. Spain Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. China Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 185. China Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 186. China Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 187. China Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 188. China Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. China Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. India Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 191. India Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 192. India Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 193. India Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 194. India Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. India Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Japan Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 197. Japan Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 198. Japan Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 199. Japan Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 200. Japan Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. Japan Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Australia Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 203. Australia Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 204. Australia Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 205. Australia Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 206. Australia Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. Australia Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. South Korea Medications for Alcohol Use Disorder Market Size, 2017-2032 (USD Million)
TABLE 209. South Korea Medications for Alcohol Use Disorder Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 210. South Korea Medications for Alcohol Use Disorder Market Size, by Injectables, 2017-2032 (USD Million)
TABLE 211. South Korea Medications for Alcohol Use Disorder Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 212. South Korea Medications for Alcohol Use Disorder Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. South Korea Medications for Alcohol Use Disorder Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Global Medications for Alcohol Use Disorder Market Share, by Key Player, 2025
TABLE 215. Global Medications for Alcohol Use Disorder Market, Key Experts

Companies Mentioned

  • Alkermes
  • Ambica Pharma
  • Amigoz Lifesciences
  • Care Formulation Labs Private Limited
  • Consern Pharma Limited
  • Dhritee Impex
  • Eisai Pharmaceuticals India Pvt Ltd
  • Intas Pharmaceuticals Ltd.
  • Johnlee Pharmaceuticals Pvt. Ltd.
  • Lifegenix (Div. of Lifecare Neuro Products Ltd.)
  • Mallinckrodt Pharmaceuticals
  • Marshall Healthcare
  • Odyssey Pharmaceuticals
  • Rusan Pharma
  • Salvavidas Pharmaceutical Pvt. Ltd.
  • Sanofi S.A.
  • Schwitz Biotech
  • Sun Pharmaceutical Industries Ltd.
  • Taj Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.

Related Topics

Related Reports

Alcohol Use Disorder Market - Global Forecast 2026-2032 - Product Image

Alcohol Use Disorder Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Alcohol Use Disorder - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Image

Alcohol Use Disorder - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • 127 Pages
  • Global
From
Alcohol Use Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Alcohol Use Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Alcohol Use Disorder - Pipeline Insight, 2026 - Product Image

Alcohol Use Disorder - Pipeline Insight, 2026

  • Clinical Trials
  • 80 Pages
  • Global
From
Addiction Disorders Drugs Market - Global Forecast 2026-2032 - Product Image

Addiction Disorders Drugs Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.